41.000 makale bulundu

Dual targeting of melatonergic and serotonergic neurotransmissions in Parkinson's disease: role of agomelatine.

Al-Kuraishy HM, Naji MT, Abd Hasan RR, Eliwa D, Batiha GE.

Neurodegener Dis Manag · 2026-10-08

DOI: 10.1080/17582024.2026.2744191PMID: 42847162

Profiling peripheral immune cells in Parkinson's disease: A scoping review.

Recinto SJ, Jernigan Posey JE, Lefter N, Vitic Z, Overgaard MØ, Liu L, Howden AJ, Eyer K, Romero-Ramos M, Tansey MG, Stratton JA.

J Parkinsons Dis · 2026-10-08

DOI: 10.1177/1877718x261479505PMID: 42847443

Update on somatic mutations in major neurodegenerative diseases: mutational signatures in neurons and mosaicism.

Freischmidt A, Weishaupt JH.

Curr Opin Genet Dev · 2026-10-08

DOI: 10.1016/j.gde.2026.102549PMID: 42849148

Periodontitis and Parkinson's disease: a narrative review of associations, proposed mechanisms, and clinical considerations

Cheng J, Zhang X, Zhou J, Liu L, Feng J, Zhao L.

Frontiers in oral health · 2026-10-07

Progress in diagnosis and treatment of Parkinson's disease and clinical application and prospect of acupuncture and moxibustion treatment

Qi B, Wen Q, Zhai L.

Frontiers in medicine · 2026-10-07

Gait characteristics in people with central nervous system disorders under dual-task experimental paradigms: a scoping review.

Jin H, Zhang J, Meng X, Li J, Meng S, Fu Q.

Front Aging Neurosci · 2026-10-07

DOI: 10.3389/fnagi.2026.1807030PMID: 42909151

Management of fragile X-associated tremor ataxia syndrome: a review for clinicians.

Hall DA, González DA, Klusek J, Todd PK, O'Keefe JA, Maltman N, Montanaro FAM, Protic D, Scorr L, Malik R, Turcano P, Meyers MS, Seritan A.

Front Neurol · 2026-10-07

DOI: 10.3389/fneur.2026.1870779PMID: 42909313

Deep brain stimulation as neuroimmune-metabolic modulation in Parkinson's disease and beyond: tissue response, glial remodeling, and disease modification.

Deng H, Li X, Wang D, Peng Y, Wang M, Liang H, Wu Y, Xiao L, Pan W, Wang W, Yin S.

Front Immunol · 2026-10-07

DOI: 10.3389/fimmu.2026.1940474PMID: 42909311

Parkinsonism with Reduced Striatal Uptake on DAT-SPECT in a Patient Harboring a Novel KCND3 Variant.

Katanazaka K, Takata M, Kanai C, Matsumoto S, Matoba K, Otani M, Koto S, Sekiguchi K, Takahashi Y, Mizusawa H, Chihara N.

Cerebellum · 2026-10-07

DOI: 10.1007/s12311-026-02092-1PMID: 42842081

Beyond Histamine Blockade: Clemastine Fumarate as a Promoter of Myelin Regeneration, Inflammatory Regulation, and Neuroimmune Modulation in CNS Disorders.

Singh RK, Banerjee C, Mehan S.

J Neuroimmune Pharmacol · 2026-10-07

DOI: 10.1007/s11481-026-10321-xPMID: 42842169

Hyaluronic acid-based CeO₂ nanozymes for brain-targeted Parkinson's disease therapy: Biointerface design, multifunctional neuroprotective regulation and future perspectives: A review.

Huang Q, Sun Y, Duan Y, Chen Y, Wang L, Wu X, Guan B, Liu C.

Int J Biol Macromol · 2026-10-07

DOI: 10.1016/j.ijbiomac.2026.154770PMID: 42843479

Hyperbaric Oxygen Therapy for Physical and Cognitive Performance in Older Adults: A Systematic Review.

Mohammadi M, Fashkhami AN, Baghban AA.

J Aging Phys Act · 2026-10-07

DOI: 10.1123/japa.2025-0308PMID: 42849526